Paul Peter Tak - Net Worth and Insider Trading
Paul Peter Tak Net Worth
The estimated net worth of Paul Peter Tak is at least $1 Million dollars as of 2025-07-02. Paul Peter Tak is the CEO of Candel Therapeutics Inc and owns about 225,740 shares of Candel Therapeutics Inc (CADL) stock worth over $1 Million. Details can be seen in Paul Peter Tak's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Peter Tak has not made any transactions after 2025-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Peter Tak
Paul Peter Tak Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Peter Tak owns 1 companies in total, including Candel Therapeutics Inc (CADL) .
Click here to see the complete history of Paul Peter Tak’s form 4 insider trades.
Insider Ownership Summary of Paul Peter Tak
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CADL | Candel Therapeutics Inc | 2025-03-19 | director & President & CEO |
Paul Peter Tak Latest Holdings Summary
Paul Peter Tak currently owns a total of 1 stock. Paul Peter Tak owns 225,740 shares of Candel Therapeutics Inc (CADL) as of March 19, 2025, with a value of $1 Million.
Latest Holdings of Paul Peter Tak
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CADL | Candel Therapeutics Inc | 2025-03-19 | 225,740 | 5.04 | 1,137,730 |
Holding Weightings of Paul Peter Tak
Paul Peter Tak Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Peter Tak has made a total of 8 transactions in Candel Therapeutics Inc (CADL) over the past 5 years, including 2 buys and 6 sells. The most-recent trade in Candel Therapeutics Inc is the sale of 26,172 shares on March 19, 2025, which brought Paul Peter Tak around $229,528.
Insider Trading History of Paul Peter Tak
- 1
Paul Peter Tak Trading Performance
GuruFocus tracks the stock performance after each of Paul Peter Tak's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Peter Tak is 18.79%. GuruFocus also compares Paul Peter Tak's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Peter Tak within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Peter Tak's insider trading performs compared to the benchmark.
Performance of Paul Peter Tak
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.17 | | | | | |
| Relative Return to S&P 500(%) | 1.68 | | | | | |
Paul Peter Tak Ownership Network
Ownership Network List of Paul Peter Tak
Ownership Network Relation of Paul Peter Tak
Paul Peter Tak Owned Company Details
What does Candel Therapeutics Inc do?
Who are the key executives at Candel Therapeutics Inc?
Paul Peter Tak is the director & President & CEO of Candel Therapeutics Inc. Other key executives at Candel Therapeutics Inc include Chief Medical Officer William Garrett Nichols , Chief Scientific Officer Francesca Barone , and See Remarks Seshu Tyagarajan .
Candel Therapeutics Inc (CADL) Insider Trades Summary
Over the past 18 months, Paul Peter Tak made 6 insider transaction in Candel Therapeutics Inc (CADL) with a net sale of 160,716. Other recent insider transactions involving Candel Therapeutics Inc (CADL) include a net sale of 139,996 shares made by Seshu Tyagarajan , a net sale of 108,130 shares made by Francesca Barone , and a net sale of 101,122 shares made by William Garrett Nichols .
In summary, during the past 3 months, insiders sold 0 shares of Candel Therapeutics Inc (CADL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 628,641 shares of Candel Therapeutics Inc (CADL) were sold and 1,250,000 shares were bought by its insiders, resulting in a net purchase of 621,359 shares.
Candel Therapeutics Inc (CADL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Candel Therapeutics Inc Insider Transactions
Paul Peter Tak Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Peter Tak. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Paul Peter Tak's mailing address is: Needham Ma 02494.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
